Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 29, 2002

View Archived Issues

New vaccines reported effective against HPV and HSV infections

Fosamprenavir calcium combined with ritonavir safe and effective in HIV-infected patients

New data on the antiviral efficacy and safety of atazanavir in HIV infection

Teriparatide more effective than alendronate in postmenopausal osteoporosis

Antitumor efficacy of EMD-273063 alone or combined with IL-2

More than 30 years after its introduction, an antibiotic comes back as a novel neuroprotective drug

Enfuvirtide a focus of attention at recent HIV congress

Disappointing preliminary data and negative complete response letter for Replagal

Clinical development program begun for pramipexole in restless legs syndrome

FluINsure vaccine challenge trial commences

Novel opioid analgesics prepared and tested at Euroceltique

Psychotropic agents discovered by Sumitomo scientists

Wyeth presents new oxytocin antagonists with potential as tocolytic agents

New immunosuppressant and antitumor compound isolated at Takeda

BMS researchers present novel inhibitors of HIV reverse transcriptase

Orally active C5a receptor antagonist with potential in inflammatory conditions

Potential new kinase inhibitors for potentiating the effects or radio- and/or chemotherapy

Nabi files BLA for use of Nabi-HB in liver transplant patients

Drug pipeline for schizophrenia

GAM product evaluated in phase I trial for diabetic foot ulcers

Phase I findings for AP-5280 support initiation of phase I/II trial

Ortho Biotech licenses bone morphogenetic protein technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...